Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volulyte vs human albumin for fluid resuscitation in major burns
2011-005734-18Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Jun 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hetastarch and albumin (human) in burn injury (2 arms), sponsored by Fresenius Kabi. Primary endpoint: Cumulative fluid balance at 24 hours after burn injury. Started Jun 2012; status: completed.
02
Drugs
hetastarchalbumin (human)
03
Conditions
burn injury
Beyond the preview
Go deeper on 2011-005734-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005734-18.